Serodiagnosis of neurocysticercosis using synthetic 8-KD proteins: Comparison of assay formats

American Journal of Tropical Medicine and Hygiene

Volumn 73, Issue 4, 2005, Pages 771-776

  Scheel, Christina M ^a   Khan, Azra ^a   Hancock, Kathy ^a   Garcia, Hector H ^b   Gonzalez, Armando E ^c   Gilman, Robert H ^e   Tsang, Victor C W ^a   Mayta, H ^b   Lopez, M T ^c   Silva, M ^c   Rodriguez, S ^d   Noh, J ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^c UNIVERSIDAD NACIONAL MAYOR DE SAN MARCOS   (Peru)

^d INSTITUTO NACIONAL DE CIENCIAS NEUROLÓGICAS   (Peru)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; LECTIN; LENTIL LECTIN PURIFIED GLYCOPROTEIN; PROTEIN TS14; PROTEIN TS18VAR1; PROTEIN TSRS1; PROTEIN TSRS2VAR1; UNCLASSIFIED DRUG;

ARTICLE; ENZYME LINKED IMMUNOELECTROTRANSFER BLOT; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOREACTIVITY; NEUROCYSTICERCOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN PURIFICATION; PROTEIN SYNTHESIS; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; TAENIA SOLIUM; WESTERN BLOTTING;

LENS CULINARIS; TAENIA SOLIUM;

EID: 26844483492     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2005.73.771     Document Type: Article

References (23)

1. World Health Organization, 2002. Control of Neurocysticercosis: Report by the Secretariat. Fifty-fifth World Health Assembly; Provisional Agenda item 13.18. Washington, DC: World Health Organization. Report no. A55/23.
2. Garcia HH, Gilman RH, Tsang VC, Gonzalez AE, 1997. Clinical significance of neurocysticercosis in endemic villages. The Cysticercosis Working Group in Peru. Trans R Soc Trop Med Hyg 91: 176-178.
3. Medina MT, Rosas E, Rubio-Donnadieu F, Sotelo J, 1990. Neurocysticercosis as the main cause of late-onset epilepsy in Mexico. Arch Intern Med 150: 325-327.
4. Palacio LG, Jimenez I, Garcia HH, Jimenez ME, Sanchez JL, Noh J, Ahn L, Mora O, Giraldo M, Tsang VC, 1998. Neurocysticercosis in persons with epilepsy in Medellin, Colombia. The Neuroepidemiological Research Group of Antioquia. Epilepsia 39: 1334-1339.
5. Rajbhandari KC, 2004. Epilepsy in Nepal. Can J Neurol Sci 31: 257-260.
6. White AC Jr, 1997. Neurocysticercosis: a major cause of neurological disease worldwide. Clin Infect Dis 24: 101-113.
7. Brand JA, Tsang VC, 1989. A rapid immunoblot assay (Western blot) to detect specific antibodies for human immunodeficiency virus, Schistosoma mansoni, and Taenia soliiim (cysticercosis). J Immunoassay 10: 237-255.
8. Tsang VC, Brand JA, Boyer AE, 1989. An enzyme-linked immunoelectrotransfer blot assay and glycoprotein antigens for diagnosing human cysticercosis (Taenia solium). J Infect Dis 159: 50-59.
9. Tsang VC, Pilcher JA, Zhou W, Boyer AE, Kamango-Sollo EI, Rhoads ML, Murrell KD, Schantz PM, Gilman RH, 1991. Efficacy of the immunoblot assay for cysticercosis in pigs and modulated expression of distinct IgM/IgG activities to Taenia solium antigens in experimental infections. Vet Immunol Immunopathol 29: 69-78.
10. Pan American Health Organization, 1997. PAHO/WHO Informal Consultation on the Taeniosis/Cysticercosis Complex. Brasilia, Brazil, August 23-25, 1995. Washington, DC: Pan American Health Organization, 6-9.
11. Greene RM, Wilkins PP, Tsang VC, 1999. Diagnostic glycoproteins of Taenia solium cysts share homologous 14- and 18-kDa subunits. Mol Biochem Parasitol 99: 257-261.
12. Greene RM, Hancock K, Wilkins PP, Tsang VC, 2000. Taenia solium: molecular cloning and serologic evaluation of 14- and 18-kDa related, diagnostic antigens. J Parasitol 86:1001-1007.
13. Hancock K, Khan A, Williams FB, Yushak ML, Pattabhi S, Noh J, Tsang VC, 2003. Characterization of the 8-kilodalton antigens of Taenia solium metacestodes and evaluation of their use in an enzyme-linked immunosorbent assay for serodiagnosis. J Clin Microbiol 41: 2577-2586.
14. Hancock K, Pattabhi S, Greene RM, Yushak ML, Williams F, Khan A, Priest JW, Levine MZ, Tsang VC, 2004. Characterization and cloning of GP50, a Taenia solium antigen diagnostic for cysticercosis. Mol Biochem Parasitol 133: 115-124.
15. del Brutto OH, Rajshekhar V, White AC Jr, Tsang VC, Nash TE, Takayanagui OM, Schantz PM, Evans CA, Flisser A, Correa D, Bolero D, Allan JC, Sarti E, Gonzalez AE, Gilman RH, Garcia HH, 2001. Proposed diagnostic criteria for neurocysticercosis. Neurology 57: 177-183.
16. Wilson M, Bryan RT, Fried JA, Ware DA, Schantz PM, Pilcher JB, Tsang VC, 1991. Clinical evaluation of the cysticercosis enzyme-linked immunoelectrotransfer blot in patients with neurocysticercosis. J Infect Dis 164: 1007-1009.
17. Hancock K, Tsang VC, 1986. Development and optimization of the FAST-ELISA for detecting antibodies to Schistosoma mansoni. J Immunol Methods 92: 167-176.
18. Bradford MM, 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
19. 4) of horseradish peroxidase to antibodies for use in enzyme-linked immunosorbent assay. J Immunoassay 16: 395-418.
20. Youden WJ, 1950. Index for rating diagnostic tests. Cancer 3: 32-35.
21. Hernandez M, Beltran C, Garcia E, Fragoso G, Gevorkian G, Fleury A, Parkhouse M, Harrison L, Sotelo J, Sciutto E, 2000. Cysticercosis: towards the design of a diagnostic kit based on synthetic peptides. Immunol Lett 71: 13-17.
22. Fleury A, Beltran C, Ferrer E, Garate T, Harrison LJ, Parkhouse RM, Garcia E, Fragoso G, Costa-Cruz J, Biondi G, Agapejev S, Sciutto E, 2003. Application of synthetic peptides to the diagnosis of neurocysticercosis. Trop Med Int Health 8: 1124-1130.
23. Butler JE, 2004. Solid supports in enzyme-linked immunosorbent assay and other solid-phase immunoassays. Methods Mol Med 94: 333-372.